دورية أكاديمية
أعرض في EDS

COVID-19-Related Pulmonary Embolism: Incidence, Characteristics, and Risk Factors.

التفاصيل البيبلوغرافية
العنوان: COVID-19-Related Pulmonary Embolism: Incidence, Characteristics, and Risk Factors.
المؤلفون: Bukhari ZM; Medicine, King Abdullah International Medical Research Center (KAIMRC), Jeddah, SAU.; Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU., Alqarni MS; Medicine, King Abdullah International Medical Research Center (KAIMRC), Jeddah, SAU.; Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU., Abukhodair AW; Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU., Alzahrani AS; Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU., Alzahrani A; Medicine, King Abdullah International Medical Research Center (KAIMRC), Jeddah, SAU.; Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU., Alsrhani H; Department of Medical Imaging, King Abdulaziz Medical City National Guard Hospital, Jeddah, SAU., Alasadi F; Department of Medical Imaging, King Abdulaziz Medical City National Guard Hospital, Jeddah, SAU., Alotaibi AM; Department of Radiology, King Abdulaziz Medical City National Guard Hospital, Jeddah, SAU., Althobaiti M; Radiology, King Abdullah International Medical Research Center (KAIMRC), Jeddah, SAU.; Department of Radiology, King Abdulaziz Medical City National Guard Hospital, Jeddah, SAU.; Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
المصدر: Cureus [Cureus] 2021 Nov 19; Vol. 13 (11), pp. e19738. Date of Electronic Publication: 2021 Nov 19 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Introduction:  The 2020 world pandemic caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initially reported in December 2019 in Wuhan, China, which has since then spread globally. Several studies on patients with coronavirus disease 2019 (COVID-19) describe a high risk of pulmonary embolism (PE). The majority of PEs in patients with COVID-19 were in the segmental arteries. Therefore, this study aims to determine the rate of PE in patients with COVID-19 at King Abdulaziz Medical City in Jeddah, Saudi Arabia. Other risk factors of PE were taken into consideration.
Patients and Methods:  This study is a single-center, retrospective, cross-sectional study that used a non-probability consecutive sampling technique to select the patients. The local institutional review boards approved the study protocol. Overall, 91 consecutive patients who were older than 18 years of age and who had a computerized tomography (CT) pulmonary angiography were included in this study.
Results:  Ninety-one patients met the inclusion and exclusion criteria, of whom 46 (50.5%) were females and 45 (49.5%) were males. The study population's age ranged from 19 to 87 with a mean age of 59 ± 15 years. PE was documented in 11 patients (12.1%). Seventy-three patients underwent CT scan angiography during COVID-19 manifestation, while 18 patients had it after recovering from COVID-19. Out of the 11 patients with PE, eight were diagnosed with PE while being COVID-19 positive, and three were diagnosed with PE after recovery from COVID-19.
Conclusion: Several potential clinical implications can be concluded for this study. Firstly, effective evaluation of the risk of PE in patients with COVID-19 is based on clinical findings such as chest pain, hemoptysis, lower limb edema, and, most significantly, shortness of breath. Secondly, measuring D-dimer remains an effective test for ruling out PE in patients with COVID-19 as in patients without COVID-19.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2021, Bukhari et al.)
References: Postgrad Med J. 2005 Jun;81(956):e3. (PMID: 15937197)
Infez Med. 2021 Sep 10;29(3):339-344. (PMID: 35146338)
Thromb Res. 2020 Sep;193:86-89. (PMID: 32531548)
J Med Virol. 2020 Jul;92(7):791-796. (PMID: 32181911)
Radiology. 2020 Sep;296(3):E186-E188. (PMID: 32324103)
Radiol Cardiothorac Imaging. 2020 Mar 16;2(2):e200067. (PMID: 33778561)
Eur J Intern Med. 2015 Oct;26(8):596-8. (PMID: 26365372)
Am J Emerg Med. 2020 Jul;38(7):1544.e1-1544.e3. (PMID: 32312574)
Radiology. 2020 Sep;296(3):E189-E191. (PMID: 32324102)
Lancet Respir Med. 2020 Jul;8(7):681-686. (PMID: 32473124)
Curr Opin Anaesthesiol. 2015 Apr;28(2):227-36. (PMID: 25590467)
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620962853. (PMID: 33074732)
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. (PMID: 32172226)
Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632)
Transplantation. 2020 Nov;104(11):e329-e331. (PMID: 33122591)
Aust Fam Physician. 2017 Nov;46(11):816-820. (PMID: 29101916)
JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570)
Eur Radiol. 2021 Apr;31(4):1915-1922. (PMID: 32964337)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
J Thromb Haemost. 2020 Jun;18(6):1421-1424. (PMID: 32271988)
Int J Legal Med. 2020 Jul;134(4):1275-1284. (PMID: 32500199)
Eur Heart J. 2020 May 14;41(19):1858. (PMID: 32227120)
Crit Care. 2020 Jun 2;24(1):275. (PMID: 32487122)
J Thromb Haemost. 2020 Apr;18(4):844-847. (PMID: 32073213)
Emerg Med J. 2003 Jul;20(4):319-25. (PMID: 12835339)
Thromb Res. 2020 Jul;191:9-14. (PMID: 32353746)
J Am Coll Surg. 2016 Jan;222(1):65-72. (PMID: 26616034)
Crit Care Med. 2021 Mar 1;49(3):437-448. (PMID: 33555777)
Lab Med. 2016 May;47(2):90-102. (PMID: 27016528)
Thromb Res. 2020 Jul;191:145-147. (PMID: 32291094)
Radiology. 2020 Dec;297(3):E335-E338. (PMID: 32407256)
Lancet Haematol. 2020 Jun;7(6):e438-e440. (PMID: 32407672)
Radiol Res Pract. 2021 Jan 16;2021:6649086. (PMID: 33532097)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Signal Transduct Target Ther. 2020 Oct 9;5(1):235. (PMID: 33037188)
Blood. 2020 Jul 23;136(4):489-500. (PMID: 32492712)
Thromb Haemost. 2020 Jun;120(6):937-948. (PMID: 32316065)
فهرسة مساهمة: Keywords: covid-19; ct; prevalence; pulmonary embolism; risk factors
تواريخ الأحداث: Date Created: 20211223 Latest Revision: 20231108
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8684825
DOI: 10.7759/cureus.19738
PMID: 34938617
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.19738